|
We regret to advise our pharmacy operation is closing and we are no longer accepting new website orders. We will remain available to provide customer service for any existing order. We wish to sincerely thank all our past customers for their support over many years.
Sudafed PE Sinus and Allergy and Pain Relief Tablets |
|
|
| Product Use : Sudafed PE Sinus, Allergy and Pain Relief tablets are an effective sinus pain reliever and nasal decongestant |
| Classification : | OTC Pharmacy Only Medicine
(No Prescription Required) |
Manufacturer Name : Pfizer |
| 1 packet of Sudafed PE Sinus and Allergy and Pain Relief Tablets | 48 tablets | USD $24.50 |
|
| 2 packets of Sudafed PE Sinus and Allergy and Pain Relief Tablets | 96 tablets | USD $48.34 |
|
| 3 packets of Sudafed PE Sinus and Allergy and Pain Relief Tablets | 144 tablets | USD $71.58 |
|
| 5 packets of Sudafed PE Sinus and Allergy and Pain Relief Tablets | 240 tablets | USD $118.20 |
|
Information - Sudafed PE Sinus and Allergy and Pain Relief Tablets
Sudafed PE Sinus, Allergy and Pain Relief tablets are an effective sinus pain reliever and nasal decongestant which offers 24 hour relief from the symptoms of sinus congestion and pain. In addition these tablets contain an antihistamine to quickly relieve allergic symptoms.
Do not take this medicine if you have taken paracetamol within the last four hours or if you have taken anti-histamines in the last 24 hours. This medication can make you feel drowsy and may affect your ability to drive a car or operate machinery. This medicine is not for children under 12 years.
Use
2 tablets every 4-6 hours as necessary, no more than 8 tablets in 24 hours. When to stop: Adults after a few days, Children 48 hours later except on medical advice.
Ingredients
Active Ingredients: Each tablet contains, Phenylephrine Hydrochloride 5mg, Chlorpheniramine Maleate 2mg, Paracetamol 500mg
Important notes
Phenylephrine may cause sleeplessness in some people. Chlorpheniramine may cause drowsiness. Avoid alcohol.
Keep to recommended dose.
|
